• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β和γ氨基酸取代的苯磺酰胺类化合物作为人碳酸酐酶的抑制剂

Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases.

作者信息

Balandis Benas, Šimkūnas Tomas, Paketurytė-Latvė Vaida, Michailovienė Vilma, Mickevičiūtė Aurelija, Manakova Elena, Gražulis Saulius, Belyakov Sergey, Kairys Visvaldas, Mickevičius Vytautas, Zubrienė Asta, Matulis Daumantas

机构信息

Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania.

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, LT-10257 Vilnius, Lithuania.

出版信息

Pharmaceuticals (Basel). 2022 Apr 13;15(4):477. doi: 10.3390/ph15040477.

DOI:10.3390/ph15040477
PMID:35455474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9033141/
Abstract

A series of novel benzenesulfonamide derivatives were synthesized bearing - β,γ-amino acid or - β-amino acid and thiazole moieties and their binding to the human carbonic anhydrase (CA) isozymes determined. These enzymes are involved in various illnesses, such as glaucoma, altitude sickness, epilepsy, obesity, and even cancer. There are numerous compounds that are inhibitors of CA and used as pharmaceuticals. However, most of them bind to most CA isozymes with little selectivity. The design of high affinity and selectivity towards one CA isozyme remains a significant challenge. The beta and gamma amino acid-substituted compound affinities were determined by the fluorescent thermal shift assay and isothermal titration calorimetry for all 12 catalytically active human carbonic anhydrase isozymes, showing the full affinity and selectivity profile. The structures of several compounds were determined by X-ray crystallography, and the binding mode in the active site of CA enzyme was shown.

摘要

合成了一系列带有-β,γ-氨基酸或-β-氨基酸以及噻唑部分的新型苯磺酰胺衍生物,并测定了它们与人碳酸酐酶(CA)同工酶的结合情况。这些酶参与多种疾病,如青光眼、高原病、癫痫、肥胖症甚至癌症。有许多化合物是CA的抑制剂并用作药物。然而,它们中的大多数对大多数CA同工酶的结合选择性很小。设计对一种CA同工酶具有高亲和力和选择性仍然是一项重大挑战。通过荧光热位移分析和等温滴定量热法测定了β和γ氨基酸取代化合物对所有12种具有催化活性的人碳酸酐酶同工酶的亲和力,显示了完整的亲和力和选择性概况。通过X射线晶体学确定了几种化合物的结构,并展示了它们在CA酶活性位点的结合模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/84715f169400/pharmaceuticals-15-00477-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/85c591340966/pharmaceuticals-15-00477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/92a205d6facd/pharmaceuticals-15-00477-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/cd01247eaf4b/pharmaceuticals-15-00477-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/0ca89d2ffc31/pharmaceuticals-15-00477-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/94bb60c85942/pharmaceuticals-15-00477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/6bd9db5a701e/pharmaceuticals-15-00477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/6ff3d44e7514/pharmaceuticals-15-00477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/84715f169400/pharmaceuticals-15-00477-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/85c591340966/pharmaceuticals-15-00477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/92a205d6facd/pharmaceuticals-15-00477-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/cd01247eaf4b/pharmaceuticals-15-00477-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/0ca89d2ffc31/pharmaceuticals-15-00477-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/94bb60c85942/pharmaceuticals-15-00477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/6bd9db5a701e/pharmaceuticals-15-00477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/6ff3d44e7514/pharmaceuticals-15-00477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da2e/9033141/84715f169400/pharmaceuticals-15-00477-g005.jpg

相似文献

1
Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases.β和γ氨基酸取代的苯磺酰胺类化合物作为人碳酸酐酶的抑制剂
Pharmaceuticals (Basel). 2022 Apr 13;15(4):477. doi: 10.3390/ph15040477.
2
Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II.抑制剂与人类碳酸酐酶I和II结合中电荷识别的结构分析。
J Am Chem Soc. 2007 May 2;129(17):5528-37. doi: 10.1021/ja068359w. Epub 2007 Apr 4.
3
Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases.含吡咯烷酮的甲基化和卤化苯磺酰胺作为碳酸酐酶抑制剂。
Bioorg Med Chem. 2019 Jan 15;27(2):322-337. doi: 10.1016/j.bmc.2018.12.011. Epub 2018 Dec 6.
4
4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.4-取代-2,3,5,6-四氟苯磺酰胺类作为碳酸酐酶 I、II、VII、XII 和 XIII 的抑制剂。
Bioorg Med Chem. 2013 Apr 1;21(7):2093-106. doi: 10.1016/j.bmc.2013.01.008. Epub 2013 Jan 16.
5
Intrinsic thermodynamics of high affinity inhibitor binding to recombinant human carbonic anhydrase IV.高亲和力抑制剂与重组人碳酸酐酶IV结合的内在热力学
Eur Biophys J. 2018 Apr;47(3):271-290. doi: 10.1007/s00249-017-1256-0. Epub 2017 Oct 3.
6
Thiazole-substituted benzenesulfonamides as inhibitors of 12 human carbonic anhydrases.噻唑取代的苯磺酰胺类化合物作为 12 种人碳酸酐酶的抑制剂。
Bioorg Chem. 2018 Apr;77:534-541. doi: 10.1016/j.bioorg.2018.02.004. Epub 2018 Feb 10.
7
Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.含嘧啶部分的苯磺酰胺类化合物作为人碳酸酐酶 I、II、VI、VII、XII 和 XIII 的抑制剂。
Bioorg Med Chem. 2013 Nov 15;21(22):6937-47. doi: 10.1016/j.bmc.2013.09.029. Epub 2013 Sep 20.
8
Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII.苯并脒类化合物作为碳酸酐酶 I、II、VII、XII 和 XIII 的抑制剂。
J Enzyme Inhib Med Chem. 2014 Feb;29(1):124-31. doi: 10.3109/14756366.2012.757223. Epub 2013 Jan 28.
9
4-amino-substituted benzenesulfonamides as inhibitors of human carbonic anhydrases.4-氨基取代苯磺酰胺作为人类碳酸酐酶抑制剂
Molecules. 2014 Oct 28;19(11):17356-80. doi: 10.3390/molecules191117356.
10
Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases.氟化苯磺酰胺的功能化及其对碳酸酐酶的抑制特性。
ChemMedChem. 2015 Apr;10(4):662-87. doi: 10.1002/cmdc.201402490. Epub 2015 Mar 10.

引用本文的文献

1
Synthesis of Novel Benzenesulfonamide-Bearing Functionalized Imidazole Derivatives as Novel Candidates Targeting Multidrug-Resistant Complex.新型含苯磺酰胺官能化咪唑衍生物的合成作为靶向多药耐药复合物的新型候选物
Microorganisms. 2023 Apr 3;11(4):935. doi: 10.3390/microorganisms11040935.
2
Synthesis of novel sulphamethoxazole derivatives and exploration of their anticancer and antimicrobial properties.新型磺胺甲恶唑衍生物的合成及抗癌抗菌性能研究。
PLoS One. 2023 Mar 23;18(3):e0283289. doi: 10.1371/journal.pone.0283289. eCollection 2023.

本文引用的文献

1
Synthesis and structure-affinity relationship of chlorinated pyrrolidinone-bearing benzenesulfonamides as human carbonic anhydrase inhibitors.含氯代吡咯烷酮苯磺酰胺类化合物的合成及结构与亲和力关系研究作为人碳酸酐酶抑制剂。
Bioorg Chem. 2020 Apr;97:103658. doi: 10.1016/j.bioorg.2020.103658. Epub 2020 Feb 13.
2
Theory and applications of differential scanning fluorimetry in early-stage drug discovery.差示扫描荧光法在早期药物发现中的理论与应用
Biophys Rev. 2020 Feb;12(1):85-104. doi: 10.1007/s12551-020-00619-2. Epub 2020 Jan 31.
3
Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019.
碳酸酐酶抑制剂与青光眼治疗:2013-2019 年文献及专利回顾。
Expert Opin Ther Pat. 2019 Oct;29(10):781-792. doi: 10.1080/13543776.2019.1679117. Epub 2019 Oct 15.
4
Design, synthesis and biological evaluation of 1-benzyl-5-oxopyrrolidine-2-carboximidamide derivatives as novel neuroprotective agents.设计、合成及生物评价 1-苄基-5-氧代吡咯烷-2-甲脒衍生物作为新型神经保护剂。
Eur J Med Chem. 2019 Nov 15;182:111654. doi: 10.1016/j.ejmech.2019.111654. Epub 2019 Aug 28.
5
Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013-2019).肾上腺素能激动剂和拮抗剂作为抗青光眼药物:文献和专利综述(2013-2019 年)。
Expert Opin Ther Pat. 2019 Oct;29(10):805-815. doi: 10.1080/13543776.2019.1665023. Epub 2019 Sep 9.
6
Novel therapies for glaucoma: a patent review (2013-2019).青光眼的新型疗法:专利审查(2013-2019)。
Expert Opin Ther Pat. 2019 Oct;29(10):769-780. doi: 10.1080/13543776.2019.1653279. Epub 2019 Aug 11.
7
Pyrrolidinone-bearing methylated and halogenated benzenesulfonamides as inhibitors of carbonic anhydrases.含吡咯烷酮的甲基化和卤化苯磺酰胺作为碳酸酐酶抑制剂。
Bioorg Med Chem. 2019 Jan 15;27(2):322-337. doi: 10.1016/j.bmc.2018.12.011. Epub 2018 Dec 6.
8
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).碳酸酐酶抑制剂作为抗肿瘤/抗转移药物:专利研究综述(2008-2018)。
Expert Opin Ther Pat. 2018 Oct;28(10):729-740. doi: 10.1080/13543776.2018.1508453. Epub 2018 Aug 9.
9
Sulfonamide inhibitors: a patent review 2013-present.磺胺类抑制剂:专利审查 2013 年至今。
Expert Opin Ther Pat. 2018 Jul;28(7):541-549. doi: 10.1080/13543776.2018.1487400. Epub 2018 Jun 19.
10
"To Be or Not to Be" Protonated: Atomic Details of Human Carbonic Anhydrase-Clinical Drug Complexes by Neutron Crystallography and Simulation.“生还是死”质子化:通过中子晶体学和模拟研究人碳酸酐酶-临床药物复合物的原子细节。
Structure. 2018 Mar 6;26(3):383-390.e3. doi: 10.1016/j.str.2018.01.006. Epub 2018 Feb 8.